Literature DB >> 14972535

Functional expression of CD4, CXCR4, and CCR5 in glycosphingolipid-deficient mouse melanoma GM95 cells and susceptibility to HIV-1 envelope glycoprotein-triggered membrane fusion.

Satinder S Rawat1, Julie Eaton, Stephen A Gallo, Thomas D Martin, Sherimay Ablan, Shashikala Ratnayake, Mathias Viard, Vineet N KewalRamani, Ji Ming Wang, Robert Blumenthal, Anu Puri.   

Abstract

We had previously reported that glycosphingolipids (GSL) support human immunodeficiency virus type 1 (HIV-1) entry. In this study, we further examined this issue by expressing HIV-1 receptors in GSL-deficient GM95 cells. GM95 cells expressing low levels of CD4 and CXCR4 or CCR5 did not support HIV-1 Env-mediated fusion. However, higher expression of these receptors rendered GM95 cells highly susceptible to fusion with cells expressing appropriate HIV-1 envelope glycoproteins (HIV-1 Envs). The GM95 cells exhibited a different fusion phenotype when compared with GSL(+) NIH3T3 cells bearing similar receptor levels. Fusion of GM95 targets expressing higher levels of CD4 and coreceptors occurred at 25 degrees C and was sensitive to cholesterol depletion or disruption of the cytoskeleton. In contrast, the fusion threshold of NIH3T3CD4X4/R5 targets was at >/=28 degrees C as previously reported and was insensitive to cholesterol depletion or cytoskeletal network disruption. On the basis of these observations, we propose that target membrane GSLs support HIV-1 Env-mediated fusion at low density of receptors by stabilizing receptor pools in natural targets.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14972535     DOI: 10.1016/j.virol.2003.08.042

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  11 in total

1.  Restricted lateral mobility of plasma membrane CD4 impairs HIV-1 envelope glycoprotein mediated fusion.

Authors:  Satinder S Rawat; Christina Zimmerman; Benitra T Johnson; Edward Cho; Stephen J Lockett; Robert Blumenthal; Anu Puri
Journal:  Mol Membr Biol       Date:  2008-01       Impact factor: 2.857

Review 2.  Roles for biological membranes in regulating human immunodeficiency virus replication and progress in the development of HIV therapeutics that target lipid metabolism.

Authors:  Norman J Haughey; Luis B Tovar-y-Romo; Veera Venkata Ratnam Bandaru
Journal:  J Neuroimmune Pharmacol       Date:  2011-03-29       Impact factor: 4.147

3.  Sphingolipids, cholesterol, and HIV-1: a paradigm in viral fusion.

Authors:  Satinder Singh Rawat; Mathias Viard; Stephen A Gallo; Robert Blumenthal; Anu Puri
Journal:  Glycoconj J       Date:  2006-05       Impact factor: 2.916

4.  Hyperthermia-triggered intracellular delivery of anticancer agent to HER2(+) cells by HER2-specific affibody (ZHER2-GS-Cys)-conjugated thermosensitive liposomes (HER2(+) affisomes).

Authors:  Brandon Smith; Ilya Lyakhov; Kristin Loomis; Danielle Needle; Ulrich Baxa; Amichai Yavlovich; Jacek Capala; Robert Blumenthal; Anu Puri
Journal:  J Control Release       Date:  2011-04-09       Impact factor: 9.776

5.  Establishment of mouse leukemia cell lines expressing human CD4/CCR5 using lentiviral vectors.

Authors:  Ya-Jing Li; Fu-Yan ZhuGe; Chang-Chun Zeng; Jin-Yang He; Ning Tan; Juan Liang
Journal:  Virus Genes       Date:  2016-12-28       Impact factor: 2.332

6.  Specific targeting to B cells by lipid-based nanoparticles conjugated with a novel CD22-ScFv.

Authors:  Kristin Loomis; Brandon Smith; Yang Feng; Himanshu Garg; Amichai Yavlovich; Ryan Campbell-Massa; Dimiter S Dimitrov; Robert Blumenthal; Xiaodong Xiao; Anu Puri
Journal:  Exp Mol Pathol       Date:  2010-02-01       Impact factor: 3.362

7.  Thermal stability of the human immunodeficiency virus type 1 (HIV-1) receptors, CD4 and CXCR4, reconstituted in proteoliposomes.

Authors:  Mikhail A Zhukovsky; Stéphane Basmaciogullari; Beatriz Pacheco; Liping Wang; Navid Madani; Hillel Haim; Joseph Sodroski
Journal:  PLoS One       Date:  2010-10-13       Impact factor: 3.240

8.  Elevated expression of GM3 in receptor-bearing targets confers resistance to human immunodeficiency virus type 1 fusion.

Authors:  Satinder S Rawat; Stephen A Gallo; Julie Eaton; Thomas D Martin; Sherimay Ablan; Vineet N KewalRamani; Ji Ming Wang; Robert Blumenthal; Anu Puri
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

9.  HIV-1 envelope glycoprotein-mediated fusion and pathogenesis: implications for therapy and vaccine development.

Authors:  Amy Jacobs; Himanshu Garg; Mathias Viard; Yossef Raviv; Anu Puri; Robert Blumenthal
Journal:  Vaccine       Date:  2008-01-10       Impact factor: 3.641

10.  The role of cholesterol and sphingolipids in chemokine receptor function and HIV-1 envelope glycoprotein-mediated fusion.

Authors:  Sherimay Ablan; Satinder S Rawat; Mathias Viard; Ji Ming Wang; Anu Puri; Robert Blumenthal
Journal:  Virol J       Date:  2006-12-22       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.